Clinical trials: Varenicline
Unspecified Adult Solid Tumor, Protocol Specific
Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking
RATIONALE: Varenicline tartrate may help people quit smoking by decreasing the symptoms of nicotine withdrawal. It is not yet known whether varenicline tartrate is more effective in helping people stop smoking when given together…
- Trial name
- NCT00301145
- Testing
- smoking cessation intervention, varenicline, counseling intervention
- Where
- 3 sites in United States
- Volunteers
- 1,200 people
- Sponsor
- SRI International
Dry Eye Disease
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease
The objective of this study is to evaluate the pharmacokinetics (PK) in adult Chinese subjects with dry eye disease (DED)1 after bilateral nasal spray administration of OC-01 (varenicline solution) Nasal Spray at a concentration…
- Trial name
- NCT05576415
- Testing
- Varenicline Tartrate Nasal Spray
- Where
- China
- Volunteers
- 9 people
- Sponsor
- Corxel Pharmaceuticals
Tobacco Use Disorder/Cigarette Smoking, HIV
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
Cigarette smoking is an important cause of illness and death among persons with HIV (PWH). This project will study the impact of adding contingency management (use of financial rewards) to receiving medications and counseling on…
- Trial name
- NCT07835555
- Testing
- nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster
- Where
- 5 sites in United States
- Volunteers
- 794 people
- Sponsor
- Yale University
Smoking Cessation, Stress
Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment
This open-label study will evaluate hydroxyzine, a first-generation antihistamine, combined with varenicline, to help smokers abstain from smoking during a 12-week trial period by diminishing the nausea, stress, anxiety, and…
- Conditions
- Smoking Cessation, Stress, Sleep Disturbance, Nausea
- Trial name
- HAVE (NCT04188106)
- Testing
- Varenicline Pill, Hydroxyzine Pill
- Where
- 2 sites in United States
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Rose Research Center, LLC
Smoking Cessation
Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)
The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in this surveillance, and 3)factors…
- Trial name
- NCT00772941
- Testing
- Varenicline
- Volunteers
- 3,939 people
- Sponsor
- Pfizer
Smoking Cessation, Insurance Coverage
Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit
This study is based on the hypothesis that access to smoking cessation treatment (SCT) reimbursement may significantly increase the number of successful quitters in a population of smokers motivated to quit by: 1) increasing the…
- Trial name
- ACCESSATION (NCT00818207)
- Testing
- Full Smoking Cessation Treatment Coverage (100%), No Smoking Cessation Treatment Coverage (0%)
- Where
- 56 sites in Canada
- Volunteers
- 1,380 people, healthy volunteers welcome
- Sponsor
- Pfizer
Smoking Cessation
Smoking Cessation Treatment for Head and Neck Cancer Patients
This is a pilot research study examining the use of varenicline (Chantix) and the nicotine patch. The study is designed to find out whether one of these medications is more effective for smoking cessation with head and neck…
- Trial name
- NCT00931021
- Testing
- Varenicline (Chantix), Nicotine Patch
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- Yale University
Cigarette Smoking, Nicotine Dependence
Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
The purpose of this study is to ascertain: 1) the rate of smoking cessation obtained using an adaptive treatment algorithm developed in previous clinical trials, in order to calculate cost-effectiveness of the treatment; 2) the…
- Trial name
- LiveForLife2 (NCT01560507)
- Testing
- varenicline (Chantix), bupropion (Zyban), nicotine patches
- Where
- 2 sites in United States
- Volunteers
- 19 people
- Sponsor
- Duke University
Smokers
Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect management and compliance…
- Trial name
- NCT00781599
- Testing
- Chantix, Adherence Counseling, Standard Counseling
- Where
- United States
- Volunteers
- 72 people
- Sponsor
- Nikki Nollen, PhD, MA
Nicotine Dependence
Human Laboratory Study Of Varenicline in Smokers
The purpose of this study is to test the ways that a drug called varenicline helps smokers to quit smoking. Varenicline is also called Chantix® and is approved by the United States Food and Drug Administration (FDA) to help…
- Trial name
- NCT00709696
- Testing
- Varenicline
- Where
- United States
- Volunteers
- 7 people, healthy volunteers welcome
- Sponsor
- University of Minnesota
Smoking, Tobacco Use Disorder
Chantix & Bupropion for Smoking Cessation
The overarching goal of this line of research is to increase smoking abstinence rates using a combination of existing pharmacotherapies.
- Trial name
- ChanBan (NCT00587769)
- Testing
- Bupropion SR & Varenicline
- Where
- United States
- Volunteers
- 38 people, healthy volunteers welcome
- Sponsor
- Mayo Clinic
Friedreich's Ataxia
Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
The purpose of this study is to determine if varenicline is effective in treating symptoms of Friedreich's ataxia.
- Trial name
- NCT00803868
- Testing
- varenicline
- Where
- 2 sites in United States
- Volunteers
- 28 people
- Sponsor
- University of South Florida
Smoking Cessation
An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation
Open-label comparison of standard 12-week regimen of varenicline with standard 10-week regimen of transdermal nicotine patch for smoking cessation.
- Trial name
- NCT00143325
- Testing
- varenicline (CP-526,555)
- Where
- 22 sites in United States, Belgium and 3 more
- Volunteers
- 730 people
- Sponsor
- Pfizer
Cigarette Smoking, Obesity
Pre to Postoperative Smoking Cessation
The study will evaluate the feasibility of integrating an intensive pre- post-surgical smoking cessation intervention into a hospital setting, and assess measures of postsurgical recovery as a function of smoking cessation status.
- Trial name
- NCT02683161
- Testing
- Varenicline, Contingency Management, Behavioral Counseling
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Johns Hopkins University
Smoking Cessation
A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation
The purpose of the study is to measure the safety and efficacy of three doses of varenicline for smoking cessation.
- Trial name
- NCT00150241
- Testing
- CP-526,555 (varenicline)
- Where
- 7 sites in United States
- Volunteers
- 625 people
- Sponsor
- Pfizer
Smoking Cessation
Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of escalating multiple oral doses of varenicline AMT 8 controlled release formulation for 14 days in adult smokers.
- Trial name
- NCT00527150
- Testing
- Varenicline Tartrate
- Where
- 2 sites in United States
- Volunteers
- 48 people
- Sponsor
- Pfizer
Tobacco Smoking
Financial Incentives for Homeless Smokers: A Community-based RCT
This community-based randomized controlled trial will test the effect of contingent financial rewards on smoking abstinence among homeless-experienced adult cigarette smokers.
- Trial name
- NCT04445662
- Testing
- Financial incentives, Varenicline, Tobacco coaching
- Where
- United States
- Volunteers
- 184 people
- Sponsor
- Massachusetts General Hospital
Craving, Smoking
Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia
The objective of this study is to determine the mechanisms by which varenicline, an effective smoking cessation treatment, protects against relapse.
- Conditions
- Craving, Smoking, Schizophrenia
- Trial name
- NCT01850953
- Testing
- Varenicline
- Where
- Canada
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Centre for Addiction and Mental Health
Malformations
Varenicline Pregnancy Cohort Study
A prospective population-based cohort study to examine whether varenicline use during pregnancy is associated with an increased risk of major congenital malformations in infants above that associated with smoking during pregnancy.
- Trial name
- NCT01290445
- Testing
- varenicline, cigarette smoke from maternal smoking, Non-Exposure
- Volunteers
- 885,185 people
- Sponsor
- Pfizer
Nicotine Dependence
Cessation Screening Project
This project will use the Multiphase Optimization Strategy (MOST) to guide the development of optimized treatment strategies for the two most effective smoking cessation medications (Combination Nicotine Replacement [C-NRT] and…
- Trial name
- NCT04188873
- Testing
- Preparation Varenicline and Standard Duration Varenicline, Preparation Varenicline and Extended Duration Varenicline, Standard Duration Varenicline
- Where
- 2 sites in United States
- Volunteers
- 538 people, healthy volunteers welcome
- Sponsor
- University of Wisconsin, Madison